Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses-Reference-Cited by-同舟云学术

Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses

Published:2021-03-11 Issue:9 Volume:21 Page:1181-1197
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Safary Azam¹²^ORCID,Moghaddas-Sani Hakimeh³^ORCID,Akbarzadeh-Khiavi Mostafa⁴^ORCID,Khabbazzi Alireza¹^ORCID,Rafi Mohammad A.⁵^ORCID,Omidi Yadollah⁶^ORCID

Affiliation:

1. Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2. Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran

3. School of Life and Environmental Sciences, The University of Sydney, NSW Australia

4. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

5. Department of Neurology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvanian USA

6. Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, Florida USA

Funder

funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1895746

Reference166 articles.

1. Treatment of lysosomal storage disorders: successes and challenges

2. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises

3. Author Correction: Lysosomal storage diseases

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-amplifying mRNA vaccines: Mode of action, design, development and optimization;Drug Discovery Today;2022-11

2. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models;Experimental Biology and Medicine;2022-08-23

3. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art;Hematology/Oncology Clinics of North America;2022-08

4. 3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers;ChemBioChem;2022-04-07